contrastenhanc
ultrasound
ceu
allow
insight
microperfus
variou
tissu
ultrason
wave
ceu
becom
popular
recent
year
alreadi
integr
clinic
routin
intern
medicin
sinc
first
guidelin
ceu
particularli
use
context
support
diagnost
liver
spleen
well
kidney
cancer
especi
celli
et
al
provid
result
high
sensit
specif
accuraci
regard
diagnosi
benign
malign
liver
review
rettenbach
confirm
result
suggest
ceu
imag
modal
choic
differenti
focal
liver
lesion
may
replac
expens
imag
techniqu
like
current
guidelin
european
feder
societi
ultrasound
medicin
biolog
efsumb
introduc
ceu
nonhepat
applic
concern
musculoskelet
area
applic
use
especi
describ
inflammatori
joint
diseas
howev
ceu
also
appli
assess
microperfus
surrog
paramet
vital
bone
muscl
previou
report
applic
sulfur
hexafluorid
contrast
agent
bracco
imag
milan
itali
intern
medicin
demonstr
complic
rate
low
contrast
studi
regard
safeti
analysi
univers
trauma
orthoped
ultrasound
center
focus
exclus
musculoskelet
indic
ceu
specif
highlight
applic
benefit
trauma
orthoped
surgeri
contrast
agent
commonli
use
ceu
examin
consist
million
sulfur
hexafluorid
bubbl
phospholipid
shell
echogen
poorli
solubl
ga
oscil
measur
upon
collis
ultrason
sulfur
hexafluorid
contrast
agent
microbubbl
almost
larg
erythrocyt
therefor
remain
intravascular
capillari
inject
sulfur
hexafluorid
contrast
agent
present
high
reflect
allow
visual
tissu
averag
vivo
halflif
microbubbl
minut
rang
minut
sulfur
hexafluorid
contrast
agent
excret
kidney
therefor
use
patient
renal
dysfunct
contrast
agent
comput
tomographi
ct
magnet
reson
imag
mri
contraind
sulfur
hexafluorid
contrast
agent
interact
organ
system
apart
lung
liver
microvesicl
extract
bodi
within
minut
phospholipid
shell
metabol
liver
furthermor
sulfur
hexafluorid
contrast
agent
deposit
human
bodi
like
mri
contrast
agent
gadolinium
serial
applic
identifi
human
anim
brain
liver
skin
addit
sulfur
hexafluorid
contrast
agent
lower
sideeffect
profil
mri
contrast
agent
contraind
mri
like
implant
cardiac
pacemak
defibril
system
insulin
pump
cochlear
implant
metal
splinter
vascular
clip
made
ferromagnet
materi
tattoo
metalcontain
pigment
nonremov
pierc
made
magnet
materi
allerg
reaction
incompat
gadolinium
econom
aspect
high
expenditur
time
increas
cost
appli
ceu
examin
moreov
ceu
easili
access
quick
use
well
toler
patient
allow
realtim
diagnost
sinc
musculoskelet
ceu
examin
appli
assess
microperfus
tendon
well
osseou
perfus
heal
infect
nonunion
surround
variou
clinic
issu
among
multipl
interact
relationship
strong
correl
could
demonstr
ceusbas
muscl
perfus
deltoid
supraspinatu
muscl
shoulder
function
surgeri
potenti
allow
outcom
predict
eg
tendon
integr
rotat
cuff
repair
preoper
ceu
furthermor
ceusbas
quantif
osseou
microperfus
allow
identif
infect
fractur
nonunion
relat
heal
process
longbon
fractur
consid
perfus
one
import
paramet
muscl
function
bone
heal
goal
provid
detail
safetyfocus
profil
diagnost
valu
sulfur
hexafluorid
contrast
agent
applic
ceu
examin
especi
musculoskelet
issu
trauma
orthoped
surgeri
knowledg
largest
monocentr
databas
musculoskelet
ceu
examin
comprehens
databas
contrast
agent
applic
includ
demograph
data
individu
concomit
diseas
eg
cardiac
pulmonari
renal
metabol
drugrel
concomit
diseas
risk
factor
biometr
data
patient
allow
us
creat
sideeffect
analysi
regard
concomit
diseas
individu
patient
tabl
advers
event
ae
caus
contrast
agent
complic
applic
also
regist
aim
studi
evalu
safeti
profil
sulfur
hexafluorid
contrast
agent
associ
musculoskelet
indic
clinic
set
summar
ceu
potenti
diagnost
modal
manifold
indicationsappl
monocentr
regist
studi
base
data
degum
german
societi
ultrasound
medicin
accredit
univers
ultrasound
center
affili
center
trauma
orthoped
surgeri
studi
conduct
accord
declar
helsinki
current
form
approv
ethic
committe
heidelberg
regist
german
clinic
trial
regist
individu
particip
ceu
studi
regist
inform
side
effect
eg
joint
flank
pain
approv
respect
studi
protocol
given
written
inform
consent
data
studi
patient
underw
musculoskelet
ceu
examin
sulfur
hexafluorid
contrast
agent
includ
regist
inform
includ
among
data
patient
characterist
age
sex
bmi
smoker
statu
asa
score
indic
surgeri
complic
examin
well
potenti
exist
individu
concomit
diseas
particip
inform
studi
relev
data
store
monitor
use
pseudonym
publish
final
analysi
exclus
criteria
applic
ceu
histori
recent
myocardi
infarct
intracardi
rightleft
shunt
uncontrol
fluctuat
blood
pressur
sever
respiratori
diseas
pulmonari
arteri
hypertens
pah
sever
acut
respiratori
syndrom
sar
pregnanc
breastfeed
miss
studi
evid
known
allerg
reaction
sulfur
hexafluorid
contrast
agent
well
similar
contrast
agent
product
characterist
contrast
patient
younger
year
exclud
consid
contraind
sulfur
hexafluorid
contrast
agent
current
state
scientif
knowledg
patient
expos
addit
health
damag
addit
patient
show
advers
event
contrast
agent
exclud
studi
patient
receiv
ceu
examin
particip
musculoskelet
ceu
studi
conduct
institut
sinc
primarili
includ
studi
overview
clinicalradiolog
examin
timelin
followup
examin
everi
includ
studi
list
tabl
muscular
ceu
studi
includ
periop
perfus
assess
deltoid
muscl
patient
cuff
tear
arthropathi
proxim
humeru
fractur
treat
revers
shoulder
philo
plate
proxim
humer
intern
lock
system
depuy
raynham
us
anoth
key
aspect
muscular
ceu
investig
supraspinatu
muscl
microperfus
patient
traumat
degen
supraspinatu
tendon
tear
kunzet
al
data
yet
publish
strong
correl
could
demonstr
pre
postop
muscl
perfus
shoulder
function
risk
postop
figur
studi
involv
muscular
system
healthi
contralater
side
routin
examin
well
compar
tissu
perfus
patient
treat
revers
shoulder
arthroplasti
got
addit
power
doppler
examin
visual
perfus
deltoid
tere
minor
muscl
ultrasound
examin
categor
perfus
qualit
minim
perfus
maximum
perfus
significantli
weaker
deltoid
perfus
oper
shoulder
could
regard
detect
osseou
microperfus
patient
longbon
fractur
nonunion
figur
well
high
tibial
open
wedg
osteotomi
figur
lower
limb
varu
malalign
examin
visual
analyz
perfus
fractur
osteotomi
gap
studi
intend
decod
process
bone
regener
respect
osseou
microperfus
differ
point
time
analyz
mechan
fail
consolid
especi
infect
gener
siemen
acuson
siemen
healthin
erlangen
germani
use
ceu
examin
purpos
devic
operatordepend
comparison
studi
addit
philip
epiq
philip
healthcar
hamburg
germani
use
ceu
investig
standard
conduct
studi
set
adjust
accord
recommend
approv
secondgener
sulfur
hexafluorid
contrast
agent
administ
bolu
via
peripher
venou
cathet
cubit
vein
forearm
quantif
perfus
via
disruptionreplenish
kinet
loop
constant
venou
infus
feasibl
musculoskelet
issu
measur
quantit
semiquantit
tissu
paramet
use
cardiolog
chose
quantifi
via
bolu
administr
sulfur
hexafluorid
contrast
agent
bolu
alway
rins
ml
salin
solut
nacl
subsequ
ceu
examin
siemensspecif
siemen
medic
solut
usa
inc
malvern
pa
usa
contrast
puls
sequenc
mode
start
relev
bodi
region
respect
studi
case
second
video
record
dual
view
contrast
convent
bmode
ultrasound
devic
afterward
video
clip
evalu
use
design
commerci
avail
quantif
softwar
bracco
imag
milan
itali
provid
quantit
inform
muscl
tendon
osseou
util
sulfur
hexafluorid
contrast
agent
dose
vari
previous
present
studi
depend
number
investig
issu
tabl
ultrasound
examin
skelet
issu
nonunion
osteotomi
fractur
standard
dose
ml
establish
muscular
applic
ml
per
shoulder
ml
total
appli
interv
minut
complet
elimin
depend
whether
deltoid
revers
shoulder
arthroplasti
proxim
humeru
fractur
devic
comparison
supraspinatu
rotat
cuff
repair
muscl
perfus
investig
repeat
sulfur
hexafluorid
contrast
agent
inject
requir
ceu
examin
caus
increas
movement
normal
breath
excurs
cough
sneez
gener
agit
lack
complianc
oper
contrast
agentassoci
ae
includ
analysi
wherea
contrast
agentindepend
ae
usual
reaction
inject
site
cubit
vein
heat
pain
reposit
needl
document
includ
evalu
contrast
agentassoci
ae
classifi
accord
degre
sever
either
mild
moder
mild
disin
drug
treatmentsupportmoder
disin
drug
treatmentsupportsever
transient
disin
drug
treatmentsupport
studi
total
musculoskelet
ceu
examin
consult
perform
patient
tabl
sinc
three
hundr
thirtysix
patient
women
men
mean
age
year
better
overview
divid
studi
two
group
muscular
skelet
three
hundr
twentyeight
muscular
skelet
patient
smoker
former
smoker
muscular
skelet
patient
nonsmok
tabl
comorbid
studi
cohort
includ
cardiovascular
arteri
hyperhypotens
arrhythmia
coronari
heart
diseas
myocardi
infarct
month
cardiac
insuffici
pulmonari
bronchial
asthma
obstruct
sleep
apnea
syndrom
osa
renal
renal
insuffici
hypokalemia
metabol
niddmiddm
hyperhypothyroid
dyslipidemia
nonspecif
hepatopathi
drugassoci
penicillin
variou
antibiot
contrast
agent
iodin
analges
statin
local
anaesthet
muscl
relax
diseas
total
number
ae
studi
categor
mild
moder
sever
three
tabl
everi
document
agentassoci
ae
took
place
within
first
ten
minut
sulfur
hexafluorid
contrast
agent
administr
ceu
examin
interven
necessari
one
reaction
contrast
agent
sever
two
mild
tabl
gener
correspond
total
rate
mild
moder
sever
aesexamin
report
ae
frequenc
rate
sever
aesexamin
gener
ae
occur
promptli
first
applic
three
ae
signific
correl
ae
mean
volum
contrast
agent
per
patient
mean
volum
contrast
agent
per
consult
well
serious
side
effect
tabl
particip
show
advers
reaction
first
applic
contrast
agent
also
studydepend
multipl
applic
followup
appoint
extravas
sulfur
hexafluorid
contrast
agent
cannula
malposit
strictli
prevent
report
two
ae
case
case
demonstr
mild
degre
sever
selflimit
patient
requir
medic
support
tabl
direct
associ
occurr
side
effect
administr
sulfur
hexafluorid
contrast
agent
evid
similar
symptom
report
intraven
inject
typic
mild
side
effect
report
piscalgia
et
includ
moder
hypotens
headach
dizzi
discomfort
nausea
vomit
sensat
warmth
itch
case
report
woman
schedul
revers
shoulder
arthroplasti
rsa
due
posttraumat
glenohumer
arthriti
preoper
consult
reveal
medicationcontrol
hypertens
hypothyroid
well
hyperlipoproteinemia
case
athlet
woman
underw
htowo
due
varu
malalign
leg
concomit
diseas
known
phenomena
observ
case
combin
mild
symptom
domin
sensat
warmth
dizzi
discomfort
minut
intraven
applic
case
addit
report
nausea
minut
intraven
administr
second
patient
complain
subsequ
itch
headach
minut
ivadministr
tabl
moder
ae
could
observ
ceu
examin
one
three
ae
case
case
classifi
sever
man
tibial
shaft
fractur
preoper
survey
intern
medicin
council
show
medicationcontrol
hypertens
hyperlipoproteinemia
well
myocardi
infarct
month
ago
due
arteriosclerot
alter
coronari
arteri
treat
coronari
stent
immedi
within
minut
sulfur
hexafluorid
contrast
agent
applic
ml
patient
react
increas
blood
pressur
tachycardia
dyspnea
sweat
nausea
follow
immedi
afterward
patient
reaction
initi
rate
anaphylact
prednisolon
mg
dimetinden
mg
administ
intraven
addit
receiv
volum
therapi
ml
ringer
solut
condit
especi
hypertens
dyspnea
stabil
minut
without
intervent
tabl
safeti
analysi
clinic
applic
sulfur
hexafluorid
contrast
agent
musculoskelet
indic
overal
rate
report
ae
mild
moder
sever
less
relat
sever
ae
report
rate
less
result
conform
find
piscaglia
tang
confirm
observ
low
incid
rate
similar
commonli
use
drug
analget
lower
report
contrast
agent
use
xray
ct
mri
gadolinium
iodin
rate
moreov
confirm
secondgener
sulfur
hexafluorid
contrast
agent
favor
sideeffect
profil
use
musculoskelet
applic
musculoskelet
ceu
regard
safe
examin
tool
prior
studi
intern
medicin
show
contrast
agent
use
ultrasound
diagnost
associ
low
sideeffect
incid
less
gener
consid
safe
well
toler
moreov
requir
medic
examin
regard
renal
cardiac
function
prior
piscaglia
et
al
retrospect
analyz
safeti
sulfur
hexafluorid
contrast
agent
case
abdomin
applic
medic
center
overal
report
rate
sever
ae
anoth
studi
tang
et
al
report
similar
result
case
undergo
ceu
abdomin
liver
gallbladd
pancrea
spleen
kidney
superfici
thyroid
breast
lymph
node
prostat
organ
overal
incid
rate
sever
ae
advers
event
monitor
studi
patient
immedi
follow
ceu
similarli
describ
studi
includ
sulfur
hexafluorid
contrast
agent
product
insert
typic
mild
side
effect
describ
sulfur
hexafluorid
contrast
agent
product
insert
former
studi
also
observ
control
random
intraven
inject
includ
moder
hypotens
headach
discomfort
dizzi
nausea
vomit
sensat
warmth
itch
ae
includ
two
mild
ae
nausea
discomfort
dizzi
hypotens
sensat
warmth
report
analysi
may
due
vasovag
reaction
similar
symptom
usual
occur
previous
thu
independ
sulfur
hexafluorid
contrast
agent
applic
commonli
associ
placement
intraven
access
pre
postop
pain
contrast
one
patient
show
symptom
anaphylacticanaphylactoid
reaction
tachycardia
hypertens
dyspnea
note
three
ae
took
place
within
minut
contrast
agent
administr
among
three
case
ae
two
similar
concomit
diseas
includ
hypertens
metabol
disord
immedi
relat
ae
clinic
risk
profil
could
identifi
although
analysi
ae
observ
initi
applic
piscaglia
et
al
describ
one
ae
fourth
inject
sulfur
hexafluorid
contrast
agent
impli
gener
lack
reaction
previou
sulfur
hexafluorid
contrast
agent
administr
exclud
possibl
reaction
later
followup
examin
therefor
attent
spent
possibl
later
reaction
repeat
ceu
examin
patient
similar
risk
profil
either
extend
observ
minut
ceu
examin
perform
patient
undergo
ceu
examin
sulfur
hexafluorid
contrast
agent
ceu
inde
necessari
effici
emerg
protocol
need
time
treatment
patient
sever
ae
discomfort
occur
contrast
agent
inject
inject
immedi
stop
studi
design
detect
possibl
reaction
specif
risk
symptom
chang
electrocardiogram
well
chang
blood
pressur
oxygen
satur
routin
investig
examin
possibl
microvascular
effect
interact
ceu
microbubbl
also
rang
prospect
analysi
previous
welldefin
establish
individu
risk
factor
everi
patient
would
accur
classifi
detail
event
well
estim
risk
ae
caus
sulfur
hexafluorid
contrast
agent
possibl
reaction
delay
occurr
minut
examin
applic
sulfur
hexafluorid
contrast
agent
patient
discharg
might
miss
especi
patient
consid
necessari
inform
afterward
subsequ
followup
appoint
retrospect
design
patient
delay
occurr
reaction
question
possibl
caus
eg
concurr
medic
food
physic
contact
contrast
unlik
sever
advers
event
miss
strength
studi
includ
precis
defin
studi
protocol
exactli
defin
sulfur
hexafluorid
contrast
agent
applic
high
number
exclus
musculoskelet
examin
fact
ceu
examin
supervis
degum
level
iii
approv
orthoped
trauma
surgeon
anoth
advantag
monocentr
design
ensur
high
qualiti
awar
possibl
reaction
sulfur
hexafluorid
contrast
agent
administr
combin
provid
valid
data
minim
bia
musculoskelet
applic
ceu
repres
complementari
investig
approach
offer
certain
advantag
comparison
convent
use
diagnost
instrument
dcemri
contrari
mri
ct
xray
examin
costeffect
ceu
safe
use
patient
renal
impair
without
ioniz
radiat
deposit
contrast
agent
human
bodi
fear
consid
among
thing
resolut
frame
rate
ceu
whose
detail
accuraci
superior
convent
mri
ceu
may
soon
abl
support
timeconsum
costintens
medic
investig
variou
retrospect
analysi
show
ceu
sulfur
hexafluorid
contrast
agent
satisfi
safeti
profil
musculoskelet
applic
less
advers
event
comparison
rate
ae
contrast
agent
use
radiolog
examin
ct
mri
gadolinium
iodin
higher
equal
secondgener
ultrasound
sulfur
hexafluorid
contrast
agent
even
patient
higher
age
multipl
concomit
diseas
